Source:http://linkedlifedata.com/resource/pubmed/id/17612281
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-7-6
|
pubmed:abstractText |
In most cases, hepatitis A virus (HAV) infection causes a self-limiting benign acute hepatitis which confers permanent acquired immunity. However, in patients with pre-existing chronic hepatitis, HAV superinfection can cause acute hepatitis with severe progression leading to a fulminant form or linked to the risk of a rapid deterioration of hepatic function. For such a reason, some Authors recommend anti-HAV vaccination for subjects with HCV-correlated chronic hepatitis before the initiation of peg-Interferon and Ribavirin treatment. Subsequently, the real prevalence of IgG anti-HAV antibodies in patients with HC HCV-related and in healthy subjects from Eastern Sicily has been verified.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-9074
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
223-5
|
pubmed:meshHeading | |
pubmed:articleTitle |
[HAV infection in patients with chronic hepatitis C].
|
pubmed:affiliation |
Dipartimento di Medicina Interna e Patologie Sistemrniche, Ospedale Santa Marta, Università degli Studi di Catania, Italia. gaetanobertinounict@libero.it
|
pubmed:publicationType |
Journal Article,
English Abstract
|